Abstract
Update on a Phase II Study of Ixazomib with Lenalidomide As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have